About
Acquired, reformulated generics
Areas of Focus
Categories
Generic DrugDrug Delivery & FormulationNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
330
By Phase
PHASE4: 2PHASE3: 2
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT02623504Lead Sponsor
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
PHASE4Terminated
17 participants
Started: Oct 24, 2016 · Completed: Nov 1, 2018
NCT00350857Lead Sponsor
The Young Adult and Pediatric Bipolar Study
PHASE4Completed
161 participants
Started: Jul 31, 2006 · Completed: Oct 31, 2007
NCT00150605Lead Sponsor
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
PHASE3Completed
50 participants
Started: Feb 28, 2005 · Completed: Oct 31, 2005
NCT00150553Lead Sponsor
Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder
PHASE3Completed
102 participants
Started: Jan 31, 2005 · Completed: Oct 31, 2005
Locations (1)
Headquarters
Parsippany, NJ, United States
Map
Loading map...